Novel Radiobiology is an Essential Pillar for the Future of Radiation Oncology

Clin Oncol (R Coll Radiol). 2021 Nov;33(11):681-682. doi: 10.1016/j.clon.2021.09.005. Epub 2021 Sep 17.

Authors

R A Sharma¹, G D D Jones²

Affiliations

¹ UCL Cancer Institute, University College London, London, UK; Varian, a Siemens Healthineers Company, Palo Alto, California, USA. Electronic address: ricky.sharma@ucl.ac.uk.
² Leicester Cancer Research Centre, University of Leicester, Leicester, UK.

PMID: 34544641
DOI: 10.1016/j.clon.2021.09.005

No abstract available

Publication types

Editorial

MeSH terms

Forecasting
Humans
Neoplasms* / radiotherapy
Radiation Oncology*
Radiobiology